BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Intestine
,
Avian flu virus
,
Rapamycin
,
rs3825942
,
MYC
,
Response to oxidative stress
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
leukemia myelogenous, chronic
(tissue)
Summary
General Info
Body Atlas
Curated Studies
Most Correlated Studies
MSC from BM-MNC of essential thrombocythemia, polycythemia vera or chronic myeloid leukemia patients
Induced pluripotent stem cells from imatinib-sensitive chronic myelogenous leukemia samples
Pre-B cells of Swiss Webster mice with Stat5a/b conditional knockout
Chronic myelogenous leukemia cells in normoxic or hypoxic culture treated with imatinib
Leukemic cells (K562) with 20uM iron (Fe-III) mesoporphyrin or mesoporphyrin alone for 20hr
Explore Curated Studies Results
Literature
Most Relevant Literature
Myelofibrosis in Philadelphia chromosome-negative myeloproliferative neoplasms is associated with ab…
Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia.
Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Phila…
Clonal cytogenetic abnormalities after tyrosine kinase inhibitor therapy in Ph+ ALL resolution after…
Acquired genomic copy number changes in CML patients with the Philadelphia chromosome (Ph+).
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia,…
Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloge…
Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ